Infection with the pathogen Clostridium difficile is a significant source of healthcare-associated infections and estimated to account for 12 percent of all HAIs in the U.S.1 C. diff infection is the ...

April 8, 2011 — A rapid diagnostic test for Clostridium difficile has been cleared by the US Food and Drug Administration (FDA). The Cepheid Xpert C difficile/Epi test provides results in less than 45 ...

Current hospital tests for the bacterium Clostridium difficile (C. difficile) are not accurate enough and a new two-stage process should be introduced to avoid misdiagnosis and its consequences. These ...

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) has provided 510(k) clearance for the cobas® Cdiff Test to detect Clostridium difficile (C. difficile) ...

A single Clostridium difficile infection presents an array of challenges for hospitals. A December 2015 study in the American Journal of Infection Control found C. difficile infections can increase ...

Please provide your email address to receive an email when new articles are posted on . GenePOC Inc. has announced the launch and FDA clearance of its Clostridium difficile molecular test, GenePOC ...

Results from a comparison study of molecular vs. non-molecular testing for Clostridium difficile toxin have shown that molecular testing detects 35% to 54% more positive specimens than other methods.

The largest study of its kind has shown the most effective test for the diagnosis of Clostridium difficile, a bacterial infection which causes 15,000-20,000 deaths a year in hospitals in the United ...

Roche ($RHHBY) got an FDA OK for its rapid test for Clostridium difficile, picking up another regulatory gold star as it broadens its offerings on its cobas 4800 ...

PARIS (Reuters) – Sanofi said on Monday it had started late-stage trials involving 15,000 people to test a vaccine against Clostridium difficile infections (CDI), the main cause of diarrhea in ...

Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced the availability in Europe of the Simplexa C. difficile ...